Skip to main content
. 2020 Oct 15;113(6):752–759. doi: 10.1093/jnci/djaa161

Figure 2.

Figure 2.

Evaluation of the microRNA signature for overall survival (OS) (A), recurrence-free survival (RFS) (B), and metastasis-free survival (MFS) (C) in the training cohort as well as OS (D), RFS (E), and MFS (F) for human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma patients in the training cohort. The patients were stratified into either the high- or low-risk group based on signature risk score. Kaplan-Meier survival curves and log-rank P values are presented. Hazard ratios (HRs) are shown with 95% confidence intervals within parentheses. All statistical tests were 2-sided.